Similar diabetes outcomes seen with weekly dulaglutide, daily liraglutide

07/16/2014 | Healio (free registration)

A study in The Lancet found diabetes patients on once-weekly dulaglutide treatment showed A1C and hypoglycemia improvements similar to those who received once-daily liraglutide. The differences in reported adverse events were also nonsignificant in both groups, researchers noted.

View Full Article in:

Healio (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
South San Francisco, CA
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD